ACTRN12616001153404
Recruiting
未知
A randomised clinical trial to evaluate the effects of continuous positive airway pressure (CPAP) on nocturnal beat to beat blood pressure and vascular function in patients with obstructive sleep apnoea.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Obstructive sleep apnoea
- Sponsor
- The University of Western Australia
- Enrollment
- 16
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants will be individuals with obstructive sleep apnoea and who have been established on Continuous positive airway pressure (CPAP) therapy within the last three years. They will also need to be compliant with CPAP therapy (average nightly use \> 4 hours per night at the last review). Only participants whose CPAP therapy has been shown to be effective (i.e., residual AHI \<10/hr on CPAP machine download or polysomnographic assessment of control of OSA while using CPAP) will be included.
Exclusion Criteria
- •1\. Current smoker
- •2\. Alcohol consumption more than 21 standard units per week
- •3\. Significant cardiovascular disease including unstable angina, cardiac failure (NYHA \> level 2\), important arrhythmia (e.g. atrial fibrillation (AF), 2nd, 3rd degree heart block), history of myocardial infarction (MI) within last 3 months and previous history of stroke.
- •4\. Severely and inadequately controlled hypertension (i.e. BP \>180/110 mmHg).
- •5\. Severe respiratory disease but excluding those with more than moderate obstructive lung disease i.e. reduced ratio of forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC ratio) and FEV1 \< 50% or moderate restrictive lung disease i.e. FVC or total lung capacity (TLC \< 50%). However stable lung disease with less severe disease can be recruited.
- •6\. Severe nocturnal desaturation documented on polysomnography (PSG) \> 2% night sleep\-time with arterial oxygen saturation of \<85%.
- •7\. Central (non\-obstructive) sleep apnoea (central events \> 50% AHI or \> 15 events/hour).
- •8\. Predominant Cheyne\-Stokes respiration.
- •9\. Other serious medical disorders (disabling neurological disorders, life threatening malignancy, renal failure requiring dialysis, peripheral artery diseases and etc.)
- •10\. Change of medication in the last 3 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A randomised clinical trial of physical activity for the treatment of older adults with mild cognitive impairmentMild Cognitive ImpairmentSubjective Memory ComplaintsAlzheimer's DiseaseNeurological - DementiasNeurological - Neurodegenerative diseasesNeurological - Alzheimer's diseaseACTRN12605000136606icola Lautenschlager170
Completed
Phase 3
Effective management of acute whiplash injuries requires a pragmatic approach: An RCT with stratified treatmentsWhiplash associated disordersAlternative and Complementary Medicine - Pain managementInjuries and Accidents - Other injuries and accidentsACTRN12605000109606Professor Gwendolen Jull124
Completed
Not Applicable
A randomised clinical trial to evaluate the effect of reducing the shock wave frequency during shock wave lithotripsy for renal calculirological and Genital Diseases: Renal calculiUrological and Genital DiseasesRenal calculiISRCTN08124462Record Provided by the NHSTCT Register - 2006 Update - Department of Health (UK)100
Not yet recruiting
Phase 2
Evaluate the efficacy of Arjunadi lepa and Naturopathy based face mud pack in vyanga.CTRI/2022/06/042971ational Institute of Ayurveda
Completed
Phase 2
Effect of folic acid on myocardial perfusion scaCoronary artery disease (Atheroscelerosis).Atherosclerotic heart diseaseIRCT2012120111624N1Vice chancellor for Research, Tehran University of Medical Sciences40